One-Shot cancer treatment? new CAR-T therapy skips lab, aims to slash cost
NCT ID NCT07383233
Summary
This early-stage study is testing a new type of CAR-T cell therapy designed to be simpler and potentially cheaper. It aims to treat adults and teens with B-cell leukemia or lymphoma that has returned or not responded to standard treatments. Instead of modifying a patient's cells in a lab, this 'in vivo' therapy is given directly to create cancer-fighting cells inside the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.